KBLB

Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials

Retrieved on: 
Monday, April 22, 2024

ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone.

Key Points: 
  • ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone.
  • The Company has completed rearing of the first generation of its new BAM-1 parental strains as part of its spring production trial.
  • Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters for these trials.
  • Each parental strain was divided into two batches, creating a total of four separate production trial groups.

Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk

Retrieved on: 
Monday, April 15, 2024

The Company successfully launched the production trials of BAM-1, its newest and most robust recombinant spider silk production silkworm hybrid, on time and in line with its production roadmap.

Key Points: 
  • The Company successfully launched the production trials of BAM-1, its newest and most robust recombinant spider silk production silkworm hybrid, on time and in line with its production roadmap.
  • The Company's CEO remains in Asia to directly oversee the production trial of the BAM-1 parental strains and monitor their performance.
  • "Our team invested heavily in improving the robustness of our production recombinant spider silk strains based on hard lessons learned and the testing data collected in 2023.
  • To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news .

Kraig Biocraft Laboratories Signs Landmark Agreement in Vietnam's Silk Production Capital

Retrieved on: 
Monday, April 8, 2024

ANN ARBOR, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has signed a landmark agreement with the Vietnam Sericulture Association ("VSA").

Key Points: 
  • ANN ARBOR, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has signed a landmark agreement with the Vietnam Sericulture Association ("VSA").
  • As part of this agreement, the Company disclosed its production plans and schedule for the next twenty-four months to the VSA to obtain cooperation in reaching its production targets.
  • This agreement establishes a collaborative working effort between the Company and the VSA, something the Company has been actively working towards for some time.
  • This landmark agreement establishes the framework and much of the logistical support needed for the Company to achieve metric-ton levels of production.

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics

Retrieved on: 
Thursday, March 28, 2024

ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").

Key Points: 
  • ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").
  • Researchers at RPI published a paper in Microbial Cell Factories outlining a new and novel method of creating spider silk protein from waste plastics.
  • Kraig Labs' recombinant spider silk production model utilizes traditional silk production systems involving planting mulberry trees to harvest and feed the leaves to silkworms.
  • The Company's specialized silkworms have been scientifically enhanced through molecular biology to create recombinant spider silk cocoons that are reeled to produce spider silk yarns and fabrics.

Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials

Retrieved on: 
Tuesday, March 19, 2024

ANN ARBOR, Mich., March 19, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid.

Key Points: 
  • ANN ARBOR, Mich., March 19, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid.
  • Dr. Nirmal Kumar gained recognition as a leading authority in the breeding and rearing of silkworms through his 37 years of work at the Central Sericulture Research & Training Institute ("CSRTI") in India.
  • He will also assist senior management in outlining the blueprints for the planned continued expansion of production capacity in Vietnam.
  • To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news

Kraig Biocraft Laboratories Senior Management travels to Vietnam for Launch of Spring Trials

Retrieved on: 
Tuesday, March 12, 2024

ANN ARBOR, Mich., March 12, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that senior management members will travel to Vietnam this week to oversee the launch of the spring production trials and lay the groundwork for the Company's planned commercial expansion.

Key Points: 
  • ANN ARBOR, Mich., March 12, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that senior management members will travel to Vietnam this week to oversee the launch of the spring production trials and lay the groundwork for the Company's planned commercial expansion.
  • Management will closely monitor all aspects of the spring trials, which are seen as the probable blueprint for large-scale production of spider silk.
  • In addition to overseeing the spring production trials, senior management plans to lay the groundwork for further production growth, scouting and identifying down-market production partners, and finalizing agreements with private and governmental entities.
  • "We are excited to be on the verge of launching our much-anticipated spring production trials.

Kraig Biocraft Laboratories Preparing Additional Business Investment License to Advance its Business Operations

Retrieved on: 
Wednesday, March 6, 2024

ANN ARBOR, Mich., March 06, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that it is preparing a second business investment application in Vietnam as part of the planned expansion of its business operations.

Key Points: 
  • ANN ARBOR, Mich., March 06, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that it is preparing a second business investment application in Vietnam as part of the planned expansion of its business operations.
  • The Investment License application is part of the creation of a new wholly-owned subsidiary of Kraig Labs, to be named Prodigy Silk.
  • "This business investment in the highlands has been a long-term strategic goal for Kraig Labs," said Founder and CEO, Kim Thompson.
  • To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news

Kraig Biocraft Laboratories Establishes Homozygosity and Confirms BAM 1 Hybrid Optimized Ahead of Spring Production Trials

Retrieved on: 
Tuesday, February 27, 2024

Establishing homozygosity for the targeted gene in both parental strains means that the Company's new BAM 1 hybrid production system is optimized for recombinant spider silk production.

Key Points: 
  • Establishing homozygosity for the targeted gene in both parental strains means that the Company's new BAM 1 hybrid production system is optimized for recombinant spider silk production.
  • The BAM 1 hybrid represents the Company's latest innovation in the commercialization of recombinant spider silk technology.
  • Achieving homozygosity for both BAM 1 parental strains is another significant milestone in the commercialization of recombinant spider silk.
  • "Our team set an aggressive deadline for achieving homozygosity in the BAM 1 hybrid ahead of our spring production trials," said CEO and Founder, Kim Thompson.

Kraig Biocraft Laboratories Announces New Premium Spider Silk and Pima Cotton Composite Yarn

Retrieved on: 
Tuesday, February 20, 2024

ANN ARBOR, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig Labs” or "the Company"), announces the creation of its first premium yarn combining its recombinant spider silk with Pima Cotton.

Key Points: 
  • ANN ARBOR, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig Labs” or "the Company"), announces the creation of its first premium yarn combining its recombinant spider silk with Pima Cotton.
  • This yarn was designed to blend the finest quality cotton with our remarkable spider silk to create a 100% natural fiber composite yarn for use in fabrics and finished garments.
  • "It seemed only fitting that our first composite yarns be blended with Pima Cotton, a luxurious natural fiber that compliments the natural elegance of our recombinant spider silk.
  • Kraig Labs is working to establish additional spider silk and natural fiber blends to address additional subsegments in formal wear.

Kraig Biocraft Laboratories Announces New Spider Silk Production Facility in Vietnam's Silk Capital

Retrieved on: 
Tuesday, February 13, 2024

ANN ARBOR, Mich., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces it has now taken possession of its new recombinant spider silk production center in Lam Dong Province, Vietnam.

Key Points: 
  • ANN ARBOR, Mich., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces it has now taken possession of its new recombinant spider silk production center in Lam Dong Province, Vietnam.
  • This new facility is located in the heart of Vietnam's booming silk economy and will serve as the center of operations for the Company's growing spider silk production in 2024.
  • The Company selected this facility and is opening this new operations center to support the significant expansion of silk production scheduled for spring 2024.
  • We expect to have this new facility online to support these exciting milestones and the commercialization of our cost-effective, eco-friendly spider silk."